1 MILLION PATIENTS 

ON THERAPY ACROSS APPROVED
CONDITIONS WORLDWIDE*

*The worldwide patient number is largely represented by 10 countries and includes patients on therapy for these uses approved in the US: AD, asthma, CRSwNP, PN, EoE, and COPD.

THINGS TO KNOW
ABOUT DUPIXENT

HELPS REDUCE A KEY
SOURCE OF INFLAMMATION

NOT A STEROID OR AN
IMMUNOSUPPRESSANT

CAN CONTINUOUSLY WORK
EVEN IN BETWEEN DOSES

Dupixent MyWay® Copay Card

AS LITTLE AS $0* COPAY
MAY BE AVAILABLE

With the DUPIXENT MyWay® Copay Card, eligible patients with commercial health insurance may pay as little as $0* in copay per fill of DUPIXENT.

CHECK COPAY CARD
ELIGIBILITY
*THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs, including any state pharmaceutical assistance programs. Subject to the program maximum per patient per calendar year. DUPIXENT MyWay reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Additional terms and conditions apply.

NEED ADDITIONAL
PATIENT SUPPORT?

The DUPIXENT MyWay patient program makes it easier to get supplemental injection training,
understand insurance coverage, and get help scheduling prescription deliveries.

Go to Patient Support